StellarOne Corp’s Novartis NVS Stock Holding History

StellarOne Corp’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$2.38M	Buy	34,679 +112	+0.3%	+$7.41K	1.76%	15
2013 Q2	$2.19M	Buy	+34,567	New	+$2.25M	1.68%	16

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

StellarOne Corp's NVS Position: Q3 2013 in Review

StellarOne Corp increased its Novartis (NVS) stake by 0.32% in Q3 2013, buying an estimated $7.41K and bringing the position to 34,679 shares worth $2.38M. The position accounts for 1.76% of the portfolio, ranked #15.

StellarOne Corp first reported a position in NVS in Q2 2013 and has held it in 2 quarters since. 761 funds tracked by Wall St. Rank hold NVS as of Q3 2013.

StellarOne Corp held 34,679 shares of Novartis worth $2.38M as of Q3 2013.
StellarOne Corp bought 112 Novartis shares in Q3 2013, an estimated $7.41K.
Novartis made up 1.76% of StellarOne Corp's portfolio in Q3 2013, its #15 holding.
StellarOne Corp first reported a position in Novartis in Q2 2013 and has held it in 2 quarters since.
761 funds tracked by Wall St. Rank held Novartis as of Q3 2013.

Based on StellarOne Corp's 13F filing for Q3 2013, filed 12 Nov 2013.